Classification Term: 903

Phenylimidazolidines (ontology term: CHEMONTID:0002547)

Polycyclic compounds containing an imidazoline substituted by a phenyl group." []

found 7 associated metabolites at category metabolite taxonomy ontology rank level.

Ancestor: Imidazolidines

Child Taxonomies: There is no child term of current ontology term.

4-(1,3-Dihydroxy-4,4,5,5-tetramethyl-imidazolidin-2-yl)benzoic acid

C14H20N2O4 (280.14230000000003)

3-Phenyl-2-thioxoimidazolidin-4-one

3-phenyl-2-sulfanylideneimidazolidin-4-one

C9H8N2OS (192.03573179999998)

2-Imidazolidinone, 1-(3,5-dichlorophenyl)-3-(2-(1,4-dioxa-8-azaspiro(4.5)dec-8-yl)ethyl)-

1-(3,5-dichlorophenyl)-3-(2-{1,4-dioxa-8-azaspiro[4.5]decan-8-yl}ethyl)imidazolidin-2-one

C18H23Cl2N3O3 (399.11163880000004)

ARN-509

4-{7-[6-cyano-5-(trifluoromethyl)pyridin-3-yl]-8-oxo-6-sulphanylidene-5,7-diazaspiro[3.4]octan-5-yl}-2-fluoro-N-methylbenzene-1-carboximidic acid

C21H15F4N5O2S (477.0882538)

Enzalutamide

4-{3-[4-cyano-3-(trifluoromethyl)phenyl]-5,5-dimethyl-4-oxo-2-sulfanylideneimidazolidin-1-yl}-2-fluoro-N-methylbenzamide

C21H16F4N4O2S (464.0930044)

L - Antineoplastic and immunomodulating agents > L02 - Endocrine therapy > L02B - Hormone antagonists and related agents > L02BB - Anti-androgens C274 - Antineoplastic Agent > C163758 - Targeted Therapy Agent > C146993 - Androgen Receptor Inhibitor C147908 - Hormone Therapy Agent > C547 - Hormone Antagonist > C242 - Anti-Androgen COVID info from clinicaltrial, clinicaltrials, clinical trial, clinical trials Corona-virus Coronavirus SARS-CoV-2 COVID-19 SARS-CoV COVID19 SARS2 SARS

N-desmethyl enzalutamide

4-{3-[4-cyano-3-(trifluoromethyl)phenyl]-5,5-dimethyl-4-oxo-2-sulfanylideneimidazolidin-1-yl}-2-fluorobenzamide

C20H14F4N4O2S (450.0773552)

Zetidoline

1-(3-chlorophenyl)-3-[2-(3,3-dimethylazetidin-1-yl)ethyl]imidazolidin-2-one

C16H22ClN3O (307.1451312)